Response of the Civil Defense Scientific Research Center to health emergencies: from AIDS to COVID-19
Keywords:
COVID-19, SARS-CoV-2, Defensa Civil, sida, vacunas cubanas, saludAbstract
The Civil Defense Scientific Research Center (CICDC) is an institution of the Cuban civil defense system, created to deal with health disasters. Its genesis was in 1981, when the bioterrorism actions of the American government reached their climax with the introduction of hemorrhagic dengue, which generated an epidemic with more than 344 thousand sick people, 158 deaths, including 101 children.Downloads
Download data is not yet available.
References
1. Kourí GP, Guzmán MG, Bravo JR, Triana C. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981 [Internet]. Bull World Health Organ. 1989 [acceso: 26/03/2024]; 67(4):375-80. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491263/
2. Vidal L, Armenteros V, Aparicio JL, Morales I, Portuondo M. Una Salud. Educ Med Super. 2021 [acceso 15/07/2021]; 35(2): [aprox. 11 pant.] Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086421412021000200018
3. ONUSIDA. Hoja Informativa. Estadísticas mundiales sobre VIH [Internet]. ONUSISA; 2023. [acceso: 15/06/2024]. Disponible en: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_es.pdf
4. Díaz HM, Pérez MT, Lubián AL, Nibot C, Cruz O, Silva E, et al. HIV detection in Cuba: role and results of the national laboratory network. [Internet]. MEDICC Review 2011; 13(2): 9-13. DOI: 10.37757/MR2011V13.N2.4
5. Ministerio de Salud Pública. Plan Estratégico Nacional para la prevención y el control de las ITS, el VIH y las hepatitis. 2019-2023. La Habana: Ministerio de Salud Pública; 2019.
6. Machado-Zaldívar LY, Blanco-de Armas M, Dubed-Echevarría M, Díaz-Torres HM, López-Rizo LS, Pérez-Guevara MT, et al. Pretreatment HIV Drug-resistance Surveillance as a Tool for Monitoring and Control of the HIV/AIDS Epidemic in Cuba. [Internet]. MEDICC Reviw. 2021;23(2):64-8. DOI: 10.37757/MR2021.V23.N2.11
7. Rodríguez Acosta M, Dubed Echevarría M, Pérez Guevara MT, Cruz Sui O, González Sosa N, Velazquez Pupo A, et al. Experiencia organizativa del Centro de Investigaciones Científicas de la Defensa Civil en el diagnóstico de la COVID-19 [Internet]. Rev. Cubana Med Milit. 2021 [acceso: 23/01/2024]; 50(2):e2101326. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1326/859
8. Noa Romero E, Enriquez Puertas JM, Machado Zaldívar LY, González Sosa NL, Montero González TJ, Falcón Cama V, et al. SARS-CoV-2 Isolation from Cuban COVID-19 Patients [Internet]. American Journal of Rare Disorders: Diagnosis and Therapy. 2020 [acceso: 26/06/2023]; 3(1):9-15. Disponible en: https://www.sciresliterature.org/RareDisorders/AJRDDT-ID18.pdf
9. Ochoa Azze R, Chang-Monteagudo A, Climent Ruiz Y, Macías Abraham C, Valenzuela Silva, García García MA. Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. [Internet]. The Lancet Respiratory Medicine. 2022;10(8):785-95. DOI: 10.1016/S2213-2600(22)00100-X
10. Machado Zaldívar LY, Noa Romero E, López Rizo LS, Blanco de Armas M, González Sosa NL, Enríquez Puertas J, et al. Caracterización genética de aislamientos de SARS-CoV-2 en las diferentes etapas pandémicas de COVID-19 en Cuba [Internet]. Rev. Cubana de Med Milit. 2024 [acceso: 23/06/2024] 53(1):e02403209. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0138-65572024000100015&script=sci_arttext&tlng=pt
2. Vidal L, Armenteros V, Aparicio JL, Morales I, Portuondo M. Una Salud. Educ Med Super. 2021 [acceso 15/07/2021]; 35(2): [aprox. 11 pant.] Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S086421412021000200018
3. ONUSIDA. Hoja Informativa. Estadísticas mundiales sobre VIH [Internet]. ONUSISA; 2023. [acceso: 15/06/2024]. Disponible en: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_es.pdf
4. Díaz HM, Pérez MT, Lubián AL, Nibot C, Cruz O, Silva E, et al. HIV detection in Cuba: role and results of the national laboratory network. [Internet]. MEDICC Review 2011; 13(2): 9-13. DOI: 10.37757/MR2011V13.N2.4
5. Ministerio de Salud Pública. Plan Estratégico Nacional para la prevención y el control de las ITS, el VIH y las hepatitis. 2019-2023. La Habana: Ministerio de Salud Pública; 2019.
6. Machado-Zaldívar LY, Blanco-de Armas M, Dubed-Echevarría M, Díaz-Torres HM, López-Rizo LS, Pérez-Guevara MT, et al. Pretreatment HIV Drug-resistance Surveillance as a Tool for Monitoring and Control of the HIV/AIDS Epidemic in Cuba. [Internet]. MEDICC Reviw. 2021;23(2):64-8. DOI: 10.37757/MR2021.V23.N2.11
7. Rodríguez Acosta M, Dubed Echevarría M, Pérez Guevara MT, Cruz Sui O, González Sosa N, Velazquez Pupo A, et al. Experiencia organizativa del Centro de Investigaciones Científicas de la Defensa Civil en el diagnóstico de la COVID-19 [Internet]. Rev. Cubana Med Milit. 2021 [acceso: 23/01/2024]; 50(2):e2101326. Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/1326/859
8. Noa Romero E, Enriquez Puertas JM, Machado Zaldívar LY, González Sosa NL, Montero González TJ, Falcón Cama V, et al. SARS-CoV-2 Isolation from Cuban COVID-19 Patients [Internet]. American Journal of Rare Disorders: Diagnosis and Therapy. 2020 [acceso: 26/06/2023]; 3(1):9-15. Disponible en: https://www.sciresliterature.org/RareDisorders/AJRDDT-ID18.pdf
9. Ochoa Azze R, Chang-Monteagudo A, Climent Ruiz Y, Macías Abraham C, Valenzuela Silva, García García MA. Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. [Internet]. The Lancet Respiratory Medicine. 2022;10(8):785-95. DOI: 10.1016/S2213-2600(22)00100-X
10. Machado Zaldívar LY, Noa Romero E, López Rizo LS, Blanco de Armas M, González Sosa NL, Enríquez Puertas J, et al. Caracterización genética de aislamientos de SARS-CoV-2 en las diferentes etapas pandémicas de COVID-19 en Cuba [Internet]. Rev. Cubana de Med Milit. 2024 [acceso: 23/06/2024] 53(1):e02403209. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0138-65572024000100015&script=sci_arttext&tlng=pt
Published
2024-11-29
How to Cite
1.
Rodríguez Acosta M, Dubed Echevarría M, Machado Zaldivar LY, Pérez Guevara MT, Cruz Sui O, Noa Romero E, et al. Response of the Civil Defense Scientific Research Center to health emergencies: from AIDS to COVID-19. Rev Cubana Med Milit [Internet]. 2024 Nov. 29 [cited 2025 Apr. 18];53(4):e024064849. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/64849
Issue
Section
Editorial
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.
